References

  1. L.P. Aiello, M.T. Cahill, and J.S. Wong 2001 Systemic Considerations in the Management of Diabetic Retinopathy. Am J Ophthalmol. 135 (5): 760-776.
  2. S.H. Sinclair, C. Delvecchio, R. Malamut, and W. Li 2005 Diabetic Retinopathy: Treating systemic conditions aggressively can save sight. Clev Clin J Med. 72(5):447-454.
  3. M.-A. Gall, P. Hougaard, K. Borch-Johnson, and H.-K. Parving 1997 Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 314:783.
  4. N.R. Loon 2003 Diabetic Kidney Disease: Preventing Dialysis and Transplantation. Clin Diabetes. 21(2): 55-62.
  5. E.J. Chung, S.J. Kang, J.S Koo, Y.S. Choi, H.E Grossniklaus, and H.J. Koh. 2010 Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy. Yonsei Med J 52(1):151-157
  6. K. Suzuma, E. Tsuiki, M. Matsumoto, A. Fujikawa, T. Kitaoka. 2011. Retro-Mode Imaging of Fibrovascular Membrane in Proliferative Diabetic Retinopathy After Intravitreal Bevacizumab Injection. Clinical Ophthalmology. 2011 (5): 897-900.